The Journal of Emergency Medicine
Volume 24, Issue 1 , Pages 35-43 , January 2003

Electrocardiographic manifestations: narrow QRS complex tachycardias

  • Marc L Pollack, MD, PhD

      Affiliations

    • Department of Emergency Medicine, York Hospital, York, Pennsylvania, USA
    • Corresponding Author InformationReprint Address: Marc L. Pollack, MD, PhD, Department of Emergency Medicine, York Hospital, 1001 South George Street, York, PA 17405, USA
  • ,
  • William J Brady, MD

      Affiliations

    • Department of Emergency Medicine, University of Virginia Health Sciences Center, Charlottesville, Virginia, USA
  • ,
  • Theodore C Chan, MD

      Affiliations

    • Department of Emergency Medicine, University of California San Diego Medical Center, San Diego, California, USA

Received 19 June 2002 ,Accepted 6 August 2002.

References 

  1. Orejarena L, Vidaillet H, DeStefano F, Nordstrom D, Vierkant R, Smith P, et al.  Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998;31:150–157
  2. Gilbert C. Common supraventricular tachycardias (mechanisms and management). AACN Clin Issues. 2001;12:100–113
  3. Hayes J, Stewart R, Greene H. Narrow QRS ventricular tachycardia. Ann Int Med. 1991;114:460–463
  4. Pollack M, Chan T, Brady W. Electrocardiographic manifestations (aberrant ventricular conduction). J Emerg Med. 2000;19:363–367
  5. Waldo A, Wit A. Mechanisms of cardiac arrhythmias. Lancet. 1993;341:1189–1193
  6. Harrigan R, Brady W. ECG abnormalities in tricyclic antidepressant ingestion. Am J Emerg Med. 1999;17:387–393
  7. Lim S, Anantharaman V, Teo W, Goh P, Tan A. Comparison of treatment of supraventricular tachycardia by valsalva maneuver and carotid sinus massage. Ann Emerg Med. 1998;31:30–35
  8. Ornato J, Hallagan L, Reese W, Clark R, Tayal V. Treatment of paroxysmal supraventricular tachycardia in the emergency department by clinical decision analysis. Am J Emerg Med. 1988;8:555–560
  9. Ferguson S, Ellis C. Monoplegia following carotid sinus massage. J Intern Med. 1994;235:379–381
  10. Brembilla-Perrot B, Houriez P, Beurrier D, Claudon O. Influence of age on the electrophysiological mechanism of paroxysmal supraventricular tachycardias. Int J Cardiol. 2001;78:293–298
  11. Kadish A, Passman R. Mechanisms and management of paroxysmal supraventricular tachycardia. Cardiol Rev. 1999;7:254–264
  12. Accardi A, Miller R, Holmes J. Enhanced Diagnosis of narrow complex tachycardias with increased electrocardiograph speed. J Emerg Med. 2002;22:123–126
  13. Tang C, Scheinman M, Van Hare G. Use of P wave configuration during atrial tachycardia to predict site of origin. J Am Coll Cardiol. 1995;26:1315–1324
  14. Kalbfleisch S, el-Atassi R, Calkins H. Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram. J Am Coll Cardiol. 1993;21:85–89
  15. Antunes E, Cacela D, Martins S, da Silva N. New criteria for the diagnosis and treatment of atrioventricular node reentrant tachycardia. Rev Port Cardiol. 2000;19:771–786
  16. Maglana M, Kam R, Teo W. The differential diagnosis of supraventricular tachycardia using clinical and electrocardiographic features. Ann Acad Med Singapore. 2000;29:653–657
  17. Marriott H, Conover M. In: Advanced concepts in arrhythmias. St. Louis: Mosby; 1998;
  18. Wen Z, Chen S, Tai C, Chiang C. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation. 1998;98:2716–2723
  19. Schwartz M, Rodman D, Lowenstein S. Recognition and treatment of multifocal atrial tachycardia: a critical review. J Emerg Med. 1994;12:353–360
  20. Bradley D, Fischbach P, Law I, Serwer G. The clinical course of multifocal atrial tachycardia in infants and children. J Am Coll Cardiol. 2001;38:401–408
  21. DiMarco J, Seller T, Berne R. Adenosine electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation. 1983;68:1254–1263
  22. Chauhan V, Krahn A, Klein G, Skanes A. Supraventricular tachycardia. Med Clin North Am. 2001;85:193–223 ix
  23. O’Rourke D, Palac R, Schindler J, Keim S. The clinical utility of adenosine in difficult to diagnose tachyarrhythmias. Clin Cardiol. 1999;22:633–636
  24. Delle Karth G, Geppert A, Neunteufl T, Priglinger U. Amodarone versus diltiazem for rate control in critically ill patients with atrial tacyarrhythmias. Crit Care Med. 2001;29:1149–1153
  25. Gupta A, Naik A, Vora A, Lokhandwala Y. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia. J Assoc Phys India. 1999;47:969–972
  26. Alboni P, Tomasi C, Menozzi C, Bottoni N. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 2001;37:548–553
  27. Luber S, Brady W, Joyce T, Perron A. Paroxysmal supraventricular tachycardia: outcome after ED care. Am J Emerg Med. 2001;19:40–42
  28. Pudpud A, Linares M, Greenberg B. Is hospitalization necessary for treatment of SVT? Predictive variables for recurrence and negative outcome. Am J Emerg Med. 1999;17:512–516
  29. Gullestad L, Birkeland K, Molstad P, Hoyer M. The effect of magnesium versus verapamil on supraventricular arrhythmias. Clin Cardiol. 1993;16:429–434
  30. Joshi P, Deshmukh P, Salkar R. Efficacy of intravenous magnesium sulphate in supraventricular tachycrrhythmias. J Assoc Phys India. 1995;43:529–531
  31. Paul T, Bertram H, Bokenkamp R, Hausdorf G. Supraventricular tachycardia in infants, childre and adolescents: diagnosis, and pharmacological and interventional therapy. Paediatr Drugs 2000; 2:171–81
  32. Weiss R, Knight B, Bahu M, Zivin A. Long-term follow-up after radiofrequency ablation of paroxysmal supraventricular tachycardia in patients with tachycardia-induced atrial fibrillation. Am J Cardiol. 1997;80:1609–1610
  33. Chakhtoura N, Angioli R, Yasin S. Use of adenosine for pharmacological cardioversion os SVT in pregnancy. Prim. Care Update Ob Gyns. 1998;5:154
  34. Mariani P. Pharmacotherapy of pregnancy-related SVT. Ann Emerg Med. 1992;21:229

 Selected Topics: Cardiology Commentary is coordinated by Theodore Chan, MD, of the University of California San Diego Medical Center, San Diego, California and William Brady, MD, of the University of Virginia, Charlottesville, Virginia.

PII: S0736-4679(02)00665-0

doi: 10.1016/S0736-4679(02)00665-0

The Journal of Emergency Medicine
Volume 24, Issue 1 , Pages 35-43 , January 2003